Loading...

AbbVie Inc.

ABBV•NYSE
Healthcare
Drug Manufacturers - General
$190.28
$-0.55(-0.29%)

AbbVie Inc. (ABBV) Financial Performance & Income Statement Overview

Review AbbVie Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
3.71%
↑ 3.71%
Operating Income Growth
30.32%
↑ 30.32%
Net Income Growth
-12.03%
↓ 12.03%
Operating Cash Flow Growth
-17.66%
↓ 17.66%
Operating Margin
28.31%
↑ 28.31%
Gross Margin
77.46%
↑ 77.46%
Net Profit Margin
7.31%
↑ 7.31%
ROE
95.59%
↑ 95.59%
ROIC
16.28%
↑ 16.28%

AbbVie Inc. (ABBV) Income Statement & Financial Overview

Review AbbVie Inc.'s (ABBV) income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$13.34B$15.10B$14.46B$14.46B
Cost of Revenue$4.002B$4.40B$4.21B$4.20B
Gross Profit$9.34B$10.71B$10.25B$10.26B
Gross Profit Ratio$0.84$0.71$0.71$0.85
R&D Expenses$2.07B$6.77B$2.13B$1.95B
SG&A Expenses$3.29B$3.85B$4.21B$3.38B
Operating Expenses$5.61B$12.20B$6.42B$6.26B
Total Costs & Expenses$9.61B$16.59B$10.63B$10.46B
Interest Income$73.00M$92.00M$0.00$220.00M
Interest Expense$700.00M$702.00M$591.00M$726.00M
Depreciation & Amortization$2.04B$2.10B$2.08B$2.13B
EBITDA$4.40B$535.00M$4.88B$5.003B
EBITDA Ratio$0.28$0.04$0.34$0.49
Operating Income$3.73B-$1.49B$3.83B$4.00B
Operating Income Ratio$0.28$0.31$0.26$0.28
Other Income/Expenses (Net)-$2.07B-$779.00M-$1.75B-$1.85B
Income Before Tax$1.66B-$2.27B$2.08B$2.15B
Income Before Tax Ratio$0.12-$0.15$0.14$0.15
Income Tax Expense$372.00M-$2.25B$520.00M$773.00M
Net Income$1.29B-$22.00M$1.56B$1.37B
Net Income Ratio$0.10-$0.001$0.11$0.09
EPS$0.72-$0.02$0.88$0.78
Diluted EPS$0.72-$0.02$0.88$0.78
Weighted Avg Shares Outstanding$1.77B$1.77B$1.77B$1.77B
Weighted Avg Shares Outstanding (Diluted)$1.77B$1.77B$1.77B$1.77B

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;